Protein Production

Our expression system allows us to reach of recombinant protein levels that are clearly all of above those currently available. The project includes all of the steps related to the production of recombinant proteins production, with facilities and equipment specifically designed to work under the GMP (Good Manufacturing Practice) conditions.

The initial stages in the laboratory include the development, characterisation, safekeeping and storage of cells in the form of Master Cell Bank and Working Cell Bank. Once it is accomplished, the optimisation of the production process is transferred to our factory where it is escalated using bioreactors with 500L and 1000L cultures in fed-batch, and 2L, 50L, 100L, 200 L in perfusion systems.

This technology also allows the generation of stable cell lines to produce recombinant proteins with an efficient quality assurance system, thanks to the high technology equipment and qualified staff of Curaxys, therefore guaranteeing the high standards of the final product.

More on Curaxys
We focus on the research, production and commercialization of recombinant proteins added value through the utilization of CuraMab® with specific human cell lines
Our expression system allows us to reach of recombinant protein levels that are clearly above those currently available.
We developed a downstream technological platform on the basis of our own laboratory data.

Latest News

  • Curaxys obtains financing for the purchase of equipment with the help granted by Innplanta 2012
  • Curaxys hires five more technologists.
  • One of the largest biopharmaceutical projects in Europe to be started at Tecnobahía.
  • Innovaxis, a novel company for “custom medicine”
  • Strategic Alliance for cancer disease
  • UCA and Curaxys create a Cathedra in biopharmaceuticals in order to research biosimilar proteins
  • Curaxys is ranked among the world top ten companies in the research of biologic generic medicines

  • Copyright 2012 Curaxys. All Rights Reserved
    Legal Advice